SEC Company Response from HEMOSENSE INC (CIK 0001127393) — Jun 14, 2005
HEMOSENSE INC (CIK 0001127393)
Date: June 14, 2005 · CIK: 0001127393 · Accession: 0001193125-05-125217
AI Filing Summary & Sentiment
File numbers found in text: 333-123705
Letter
Via EDGAR Transmission and Facsimile Securities and Exchange Commission Division of Corporation Finance Fax: (202) 772-9218 Attention: Mary Beth Breslin Re: HemoSense, Inc. (File No. 333-123705) Acceleration Request
Dear Ms. Breslin:
Pursuant to the authorization provided in the acceleration request letter of June 10, 2005, on behalf of HemoSense, Inc. (the “Company”), we hereby respectfully request that the Securities and Exchange Commission take appropriate action to make the Company’s Registration Statement on Form S-1 effective on June 16, 2005 at 4:30 p.m. E.D.T. or as soon thereafter as practicable.
Please contact me at (650) 320-4872 should you have any questions.
Sincerely,
WILSON SONSINI GOODRICH & ROSATI
Professional Corporation
/s/ DAVID J. SAUL
David J. Saul
cc: James D. Merselis
David W. Pollak
LAZARD CAPITAL MARKETS LLC
30 ROCKEFELLER PLAZA
NEW YORK, NEW YORK 10020
June 14, 2005
Via EDGAR Transmission and Facsimile
Securities and Exchange Commission
Division of Corporation Finance
Mail Stop 6010
100 F Street, NE
Washington, DC 20549
Attention: Mary Beth Breslin
Re: HemoSense, Inc.
Registration Statement on Form S-1 (No. 333-123705)
Dear Ms. Breslin:
The undersigned, as managing underwriter for the public offering of the common stock of HemoSense, Inc., a Delaware corporation (the “Company”), hereby joins in the Company’s request that the effectiveness of the above-referenced Registration Statement on Form S-1 be accelerated so that said Registration Statement will become effective at 4:30 p.m., Washington, D.C. time, on June 16, 2005, or as soon thereafter as possible.
The number of preliminary prospectuses dated May 31, 2005 which have been distributed is as follows:
To Whom Delivered
No. of Copies
Underwriters
2,000
Individuals
Others
Total
3,150
Very truly yours,
LAZARD CAPITAL MARKETS LLC
Show Raw Text
CORRESP 1 filename1.htm Acceleration Request [WILSON SONSINI GOODRICH & ROSATI LETTERHEAD] June 14, 2005 Via EDGAR Transmission and Facsimile Securities and Exchange Commission Division of Corporation Finance Mail Stop 6010 100 F Street, NE Washington, DC 20549 Fax: (202) 772-9218 Attention: Mary Beth Breslin Re: HemoSense, Inc. (File No. 333-123705) Acceleration Request Dear Ms. Breslin: Pursuant to the authorization provided in the acceleration request letter of June 10, 2005, on behalf of HemoSense, Inc. (the “Company”), we hereby respectfully request that the Securities and Exchange Commission take appropriate action to make the Company’s Registration Statement on Form S-1 effective on June 16, 2005 at 4:30 p.m. E.D.T. or as soon thereafter as practicable. Please contact me at (650) 320-4872 should you have any questions. Sincerely, WILSON SONSINI GOODRICH & ROSATI Professional Corporation /s/ DAVID J. SAUL David J. Saul cc: James D. Merselis David W. Pollak LAZARD CAPITAL MARKETS LLC 30 ROCKEFELLER PLAZA NEW YORK, NEW YORK 10020 June 14, 2005 Via EDGAR Transmission and Facsimile Securities and Exchange Commission Division of Corporation Finance Mail Stop 6010 100 F Street, NE Washington, DC 20549 Attention: Mary Beth Breslin Re: HemoSense, Inc. Registration Statement on Form S-1 (No. 333-123705) Dear Ms. Breslin: The undersigned, as managing underwriter for the public offering of the common stock of HemoSense, Inc., a Delaware corporation (the “Company”), hereby joins in the Company’s request that the effectiveness of the above-referenced Registration Statement on Form S-1 be accelerated so that said Registration Statement will become effective at 4:30 p.m., Washington, D.C. time, on June 16, 2005, or as soon thereafter as possible. The number of preliminary prospectuses dated May 31, 2005 which have been distributed is as follows: To Whom Delivered No. of Copies Underwriters 2,000 Individuals 700 Others 450 Total 3,150 Very truly yours, LAZARD CAPITAL MARKETS LLC By: /s/ David G. McMillan, Jr. Name: David G. McMillan, Jr. Title: Managing Director of Capital Markets, Head of Debt & Equity